Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
William C. Kerr & Yu Ye. (2022) Estimating usual grams per day of marijuana use from purchases. Addiction Research & Theory 30:5, pages 360-367.
Read now
Read now
Lara N. Coughlin, Erin E. Bonar, Amy S. B. Bohnert, Frederic C. Blow, José A. Bauermeister, Yazmyn Cross, Rebecca Cunningham, Sean D. Young & Maureen A. Walton. (2022) Patterns of same-day alcohol and cannabis use in adolescents and young adults with risky alcohol use. Addiction Research & Theory 30:2, pages 89-95.
Read now
Read now
Claudia Sikorski, Cesar Leos-Toro & David Hammond. (2021) Cannabis Consumption, Purchasing and Sources among Young Canadians: The Cannabis Purchase and Consumption Tool (CPCT). Substance Use & Misuse 56:4, pages 449-457.
Read now
Read now
Nolan E. Ramer, Jennifer P. Read & Craig R. Colder. (2021) Parents’ Cannabis-Related Attitudes and Emerging Adult Offspring Cannabis Use: Testing the Mediating Effect of Perceived Parental Approval. Substance Use & Misuse 56:2, pages 308-317.
Read now
Read now
Cristina Casajuana, Hugo López-Pelayo, María Mercedes Balcells, Laia Miquel, Joan Colom & Antoni Gual. (2016) Definitions of Risky and Problematic Cannabis Use: A Systematic Review. Substance Use & Misuse 51:13, pages 1760-1770.
Read now
Read now
Mitch Earleywine, Rachel Luba, Melissa N. Slavin, Stacey Farmer & Mallory Loflin. (2016) Don’t wake and bake: morning use predicts cannabis problems. Addiction Research & Theory 24:5, pages 426-430.
Read now
Read now
Bernadette Rogerson & Susan P. Jacups. (2016) “Stressing out”: defining severity of cannabis withdrawal symptoms in Australian indigenous inmates. Journal of Substance Use 21:4, pages 368-373.
Read now
Read now
Cameron Duff & Patricia G. Erickson. (2014) Cannabis, risk and normalisation: evidence from a Canadian study of socially integrated, adult cannabis users. Health, Risk & Society 16:3, pages 210-226.
Read now
Read now
Beatrice Annaheim. (2013) Who is smoking pot for fun and who is not? An overview of instruments to screen for cannabis-related problems in general population surveys. Addiction Research & Theory 21:5, pages 410-428.
Read now
Read now
Articles from other publishers (61)
Isabella Gripe, Hilde Pape & Thor Norström. (2023) Associations Between Cannabis Use and Mental Distress in Young People: A Longitudinal Study. Journal of Adolescent Health.
Crossref
Crossref
Jakob Manthey, Maria Teresa Pons‐Cabrera, Moritz Rosenkranz & Hugo Lopez‐Pelayo. (2023) Measuring cannabis quantities in online surveys: A rapid review and proposals for ways forward. International Journal of Methods in Psychiatric Research 32:3.
Crossref
Crossref
Jordan Gette, Andrew Littlefield, Sarah Victor, Adam Schmidt & Sheila Garos. (2023) Evaluation of the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Questionnaire and its Relations to Cannabis-Related Problems. Cannabis.
Crossref
Crossref
S. J. Bartel, S. B. Sherry & S. H. Stewart. (2021) Pandemic-Related Changes in Alcohol and Cannabis Use: Comparing Retrospective Reports and Prospective Data. International Journal of Mental Health and Addiction 21:4, pages 2077-2083.
Crossref
Crossref
Alannah Hillmer, Caroul Chawar, Amel Lamri, Jacqueline Hudson, Flavio Kapczinski, Luciano Minuzzi, David C. Marsh, Lehana Thabane, Andrew D. Paterson & Zainab Samaan. (2023) Genetics of cannabis use in opioid use disorder: A genome-wide association and polygenic risk score study. PLOS ONE 18:7, pages e0289059.
Crossref
Crossref
Sophie G. Coelho & Jeffrey D. Wardell. (2023) Characterizing heterogeneity among people who use cannabis for medicinal reasons: A latent class analysis of a nationally representative Canadian sample. International Journal of Drug Policy 117, pages 104076.
Crossref
Crossref
Susan J. Yousufzai, Adam G. Cole, Mika Nonoyama & Caroline Barakat. (2023) Changes in Quantity Measures of Various Forms of Cannabis Consumption among Emerging Adults in Canada in Relation to Policy and Public Health Developments. International Journal of Environmental Research and Public Health 20:13, pages 6213.
Crossref
Crossref
Arturo Alvarez-Roldan, Teresa García-Muñoz, Juan F. Gamella, Iván Parra & Maria J. Duaso. (2023) Differentiating people who use cannabis heavily through latent class analysis. Substance Abuse Treatment, Prevention, and Policy 18:1.
Crossref
Crossref
Ashley M. Lambros, Kelly A. Sagar, M. Kathryn Dahlgren, Deniz Kosereisoglu, Celine El-Abboud, Rosemary T. Smith & Staci A. Gruber. (2023) CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure. Scientific Reports 13:1.
Crossref
Crossref
Melissa R. Hatch, Adrian J. Bravo, Alison Looby & Margo C. Hurlocker. (2023) Who’s at greatest risk? Latent profiles of alcohol and cannabis use and related consequences among college students. Addictive Behaviors 137, pages 107536.
Crossref
Crossref
Will Lawn, Claire Mokrysz, Rachel Lees, Katie Trinci, Kat Petrilli, Martine Skumlien, Anna Borissova, Shelan Ofori, Catherine Bird, Grace Jones, Michael AP Bloomfield, Ravi K Das, Matthew B Wall, Tom P Freeman & H Valerie Curran. (2022) The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls. Journal of Psychopharmacology 36:12, pages 1350-1361.
Crossref
Crossref
Brian H. Calhoun, Megan E. Patrick, Anne M. Fairlie, Scott Graupensperger, Katherine Walukevich-Dienst & Christine M. Lee. (2022) Hours high as a proxy for marijuana use quantity in intensive longitudinal designs. Drug and Alcohol Dependence 240, pages 109628.
Crossref
Crossref
David Hammond, Samantha Goodman, Elle Wadsworth, Tom P Freeman, Beau Kilmer, Gillian Schauer, Rosalie Liccardo Pacula & Wayne Hall. (2022) Trends in the use of cannabis products in Canada and the USA, 2018 – 2020: Findings from the International Cannabis Policy Study. International Journal of Drug Policy 105, pages 103716.
Crossref
Crossref
Magdalen G. Schluter & David C. Hodgins. (2022) Measuring recent cannabis use across modes of delivery: Development and validation of the Cannabis Engagement Assessment. Addictive Behaviors Reports 15, pages 100413.
Crossref
Crossref
Nicole A. Short, Mariah K. Evans, Alexa M. Raudales, Mary Shapiro, Nicole H. Weiss & Norman B. Schmidt. (2022) Anxiety sensitivity and cannabis use motives among trauma‐exposed young adult cannabis users. The American Journal on Addictions 31:3, pages 242-250.
Crossref
Crossref
Tongtong Chen, Ahmed N. Hassan & Bernard Le Foll. (2021) 3-Year Follow-up of Lower Risk Cannabis Use Patterns: Evidence from a Longitudinal Survey. The Canadian Journal of Psychiatry 67:1, pages 48-56.
Crossref
Crossref
Claude Cyr, Mellar P. Davis, Danial Schecter & Paul DaeninckClaude Cyr. 2022. Cannabis and Cannabinoid-Based Medicines in Cancer Care. Cannabis and Cannabinoid-Based Medicines in Cancer Care
235
281
.
Jason Isaacs, Sean MacKinnon, Kayla Joyce & Sherry Stewart. (2021) Reactivity to Daily Self-Monitoring of Cannabis Use in Biological Females. Cannabis 4:2, pages 17-30.
Crossref
Crossref
Kayla M. Joyce, Kara Thompson, Kimberley P. Good, Philip G. Tibbo, M. Elizabeth O'Leary, Tara S. Perrot, Amanda Hudson & Sherry H. Stewart. (2021) The impact of depressed mood and coping motives on cannabis use quantity across the menstrual cycle in those with and without pre‐menstrual dysphoric disorder. Addiction 116:10, pages 2746-2758.
Crossref
Crossref
Ellen T. Kurtzman & Kelly C. Young-Wolff. (2021) Why do Americans use marijuana?. Drug and Alcohol Dependence 226, pages 108880.
Crossref
Crossref
Eduardo Tejedor Tejada, Domiciana De la Fuente Marcos, Maria Jesus Cuesta Lozano, Juana Benedí González, Jesús Moro Aguado & Jesús Miguel Tejedor Muñoz. (2021) Concentration of tetrahidrocannabinol in joints. Drugs and Alcohol Today 21:2, pages 146-156.
Crossref
Crossref
Jason P. Connor, Daniel Stjepanović, Bernard Le Foll, Eva Hoch, Alan J. Budney & Wayne D. Hall. (2021) Cannabis use and cannabis use disorder. Nature Reviews Disease Primers 7:1.
Crossref
Crossref
Russell C. Callaghan, Marcos Sanches & Stephen J. Kish. (2020) Quantity and frequency of cannabis use in relation to cannabis-use disorder and cannabis-related problems. Drug and Alcohol Dependence 217, pages 108271.
Crossref
Crossref
Awoke Mihretu, Abebaw Fekadu, Kassahun Habtamu, Clement Nhunzvi, Sam Norton & Solomon Teferra. (2020) Exploring the concept of problematic khat use in the Gurage community, South Central Ethiopia: a qualitative study. BMJ Open 10:10, pages e037907.
Crossref
Crossref
Lucy Chester, Edward Chesney, Dominic Oliver, Jack Wilson & Amir Englund. (2020) How experimental cannabinoid studies will inform the standardized THC unit. Addiction 115:7, pages 1217-1218.
Crossref
Crossref
Tom P. Freeman & Valentina Lorenzetti. (2019) ‘Standard THC units’: a proposal to standardize dose across all cannabis products and methods of administration. Addiction 115:7, pages 1207-1216.
Crossref
Crossref
Jonathan P. Caulkins, Bryce Pardo & Beau Kilmer. (2020) Intensity of cannabis use: Findings from three online surveys. International Journal of Drug Policy 79, pages 102740.
Crossref
Crossref
Megan E. Ames, Bonnie J. Leadbeater, Gabriel J. Merrin & Kara Thompson. (2018) Patterns of marijuana use and physical health indicators among Canadian youth. International Journal of Psychology 55:1, pages 1-12.
Crossref
Crossref
Jakob Manthey, Sinclair Carr & Jürgen Rehm. (2020) Definition of a ‘standard joint equivalent’: Comment on “Who consumes most of the cannabis in Canada? Profiles of cannabis consumption by quantity”. Drug and Alcohol Dependence 206, pages 107731.
Crossref
Crossref
Russell C. Callaghan, Marcos Sanches, Claire Benny, Tim Stockwell, Adam Sherk & Stephen J. Kish. (2019) Who consumes most of the cannabis in Canada? Profiles of cannabis consumption by quantity. Drug and Alcohol Dependence 205, pages 107587.
Crossref
Crossref
Rachel L. Tomko, Kevin M. Gray, Marilyn A. Huestis, Lindsay M. Squeglia, Nathaniel L. Baker & Erin A. McClure. (2019) Measuring Within-Individual Cannabis Reduction in Clinical Trials: a Review of the Methodological Challenges. Current Addiction Reports 6:4, pages 429-436.
Crossref
Crossref
Jonathan P. Caulkins, Steve Davenport, Anhvinh Doanvo, Kyle Furlong, Aatir Siddique, Michael Turner & Beau Kilmer. (2019) Triangulating web & general population surveys: Do results match legal cannabis market sales?. International Journal of Drug Policy 73, pages 293-300.
Crossref
Crossref
Kateřina Škařupová, Nicola Singleton, João Matias & Viktor Mravčík. (2019) Surveying drug consumption: Assessing reliability and validity of the European Web Survey on Drugs questionnaire. International Journal of Drug Policy 73, pages 228-234.
Crossref
Crossref
Nacera Hanzal, Kayla Joyce, Philip Tibbo & Sherry Stewart. (2019) A Pilot Daily Diary Study of Changes in Stress and Cannabis Use Quantity Across the Menstrual Cycle. Cannabis 2:2, pages 120-134.
Crossref
Crossref
Jordan E. Stevens, Douglas Steinley, Yoanna E. McDowell, Cassandra L. Boness, Timothy J. Trull, Christopher S. Martin & Kenneth J. Sher. (2019) Toward more efficient diagnostic criteria sets and rules: The use of optimization approaches in addiction science. Addictive Behaviors 94, pages 57-64.
Crossref
Crossref
Syed Mahamad & David Hammond. (2019) Retail price and availability of illicit cannabis in Canada. Addictive Behaviors 90, pages 402-408.
Crossref
Crossref
Kara Thompson, Bonnie Leadbeater, Megan Ames & Gabriel J. Merrin. (2018) Associations Between Marijuana Use Trajectories and Educational and Occupational Success in Young Adulthood. Prevention Science 20:2, pages 257-269.
Crossref
Crossref
Adeyinka C. Adejumo, Tokunbo O. Ajayi, Oluwole M. Adegbala, Kelechi L. Adejumo, Samson Alliu, Akintunde M. Akinjero, Nnaemeka E. Onyeakusi, Ogooluwa Ojelabi & Terence N. Bukong. (2018) Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease. Liver International 38:8, pages 1475-1486.
Crossref
Crossref
Rachel L. Tomko, Nathaniel L. Baker, Erin A. McClure, Susan C. Sonne, Aimee L. McRae-Clark, Brian J. Sherman & Kevin M. Gray. (2018) Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial. Drug and Alcohol Dependence 182, pages 1-7.
Crossref
Crossref
Cesar Leos-Toro, Vicki Rynard & David Hammond. (2017) Prevalence of problematic cannabis use in Canada: Cross-sectional findings from the 2013 Canadian Tobacco, Alcohol and Drugs Survey. Canadian Journal of Public Health 108:5-6, pages e516-e522.
Crossref
Crossref
Benedikt FischerCayley RussellPamela SabioniWim van den BrinkBernard Le FollWayne HallJürgen RehmRobin Room. (2017) Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations. American Journal of Public Health 107:8, pages e1-e12.
Crossref
Crossref
Cristina Casajuana Kögel, María Mercedes Balcells-Olivero, Hugo López-Pelayo, Laia Miquel, Lídia Teixidó, Joan Colom, David John Nutt, Jürgen Rehm & Antoni Gual. (2017) The Standard Joint Unit. Drug and Alcohol Dependence 176, pages 109-116.
Crossref
Crossref
Justin C. Strickland, Joshua A. Lile & William W. Stoops. (2017) Unique prediction of cannabis use severity and behaviors by delay discounting and behavioral economic demand. Behavioural Processes 140, pages 33-40.
Crossref
Crossref
Rosalie Liccardo Pacula & Rosanna Smart. (2017) Medical Marijuana and Marijuana Legalization. Annual Review of Clinical Psychology 13:1, pages 397-419.
Crossref
Crossref
Bonnie J. LeadbeaterMegan E. AmesPaweena SukhawathanakulMurray FyfeRichard StanwickJeffrey R. Brubacher. (2017) Frequent marijuana use and driving risk behaviours in Canadian youth. Paediatrics & Child Health 22:1, pages 7-12.
Crossref
Crossref
Chandni HindochaTom P. FreemanH. Valerie Curran. (2017) Anatomy of a Joint: Comparing Self-Reported and Actual Dose of Cannabis and Tobacco in a Joint, and How These Are Influenced by Controlled Acute Administration. Cannabis and Cannabinoid Research 2:1, pages 217-223.
Crossref
Crossref
B. Annaheim & S. Legleye. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies
e168
e184
.
P. Andrea Wolf, Elske Salemink & Reinout W. Wiers. (2016) Attentional retraining and cognitive biases in a regular cannabis smoking student population. SUCHT 62:6, pages 355-365.
Crossref
Crossref
Arturo Alvarez, Juan F. Gamella & Iván Parra. (2016) Cannabis cultivation in Spain: A profile of plantations, growers and production systems. International Journal of Drug Policy 37, pages 70-81.
Crossref
Crossref
Ernest Small. 2016. Cannabis. Cannabis
229
252
.
Steven S. Davenport & Jonathan P. Caulkins. (2016) Evolution of the United States Marijuana Market in the Decade of Liberalization Before Full Legalization. Journal of Drug Issues 46:4, pages 411-427.
Crossref
Crossref
Jonathan P. Caulkins, Beau Kilmer, Peter H. Reuter & Greg Midgette. (2015) Cocaine's fall and marijuana's rise: questions and insights based on new estimates of consumption and expenditures in US drug markets. Addiction 110:5, pages 728-736.
Crossref
Crossref
Peggy van der Pol, Nienke Liebregts, Ron de Graaf, Dirk J. Korf, Wim van den Brink & Margriet van Laar. (2015) Three-Year Course of Cannabis Dependence and Prediction of Persistence. European Addiction Research 21:6, pages 279-290.
Crossref
Crossref
John R. Hughes, James R. Fingar, Alan J. Budney, Shelly Naud, John E. Helzer & Peter W. Callas. (2014) Marijuana use and intoxication among daily users: An intensive longitudinal study. Addictive Behaviors 39:10, pages 1464-1470.
Crossref
Crossref
Matthijs Blankers, Tom Frijns, Vendula Belackova, Carla Rossi, Bengt Svensson, Franz Trautmann & Margriet van Laar. (2014) Predicting Cannabis Abuse Screening Test (CAST) Scores: A Recursive Partitioning Analysis Using Survey Data from Czech Republic, Italy, the Netherlands and Sweden. PLoS ONE 9:9, pages e108298.
Crossref
Crossref
Peter Gates, Adam Jaffe & Jan Copeland. (2014) Cannabis smoking and respiratory health: Consideration of the literature. Respirology 19:5, pages 655-662.
Crossref
Crossref
Yuyan Shi. (2014) At high risk and want to quit: Marijuana use among adults with depression or serious psychological distress. Addictive Behaviors 39:4, pages 761-767.
Crossref
Crossref
Mark Asbridge, Cameron Duff, David C. Marsh & Patricia G. Erickson. (2014) Problems with the Identification of ‘Problematic' Cannabis Use: Examining the Issues of Frequency, Quantity, and Drug Use Environment. European Addiction Research 20:5, pages 254-267.
Crossref
Crossref
Peggy van der Pol, Nienke Liebregts, Ron de Graaf, Dirk J. Korf, Wim van den Brink & Margriet van Laar. (2013) Predicting the transition from frequent cannabis use to cannabis dependence: A three-year prospective study. Drug and Alcohol Dependence 133:2, pages 352-359.
Crossref
Crossref
Peggy van der Pol, Nienke Liebregts, Ron de Graaf, Dirk J. Korf, Wim van den Brink & Margriet van Laar. (2013) Validation of self‐reported cannabis dose and potency: an ecological study. Addiction 108:10, pages 1801-1808.
Crossref
Crossref
Dan Werb, Bohdan Nosyk, Thomas Kerr, Benedikt Fischer, Julio Montaner & Evan Wood. (2012) Estimating the economic value of British Columbia's domestic cannabis market: Implications for provincial cannabis policy. International Journal of Drug Policy 23:6, pages 436-441.
Crossref
Crossref